tiprankstipranks
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
US Market
MRVI
Maravai Lifesciences Holdings
RESEARCH TOOLSreports

Maravai Lifesciences Holdings (MRVI) Income Statement

410 Followers

Maravai Lifesciences Holdings Income Statement

Last quarter (Q4 2025), Maravai Lifesciences Holdings's total revenue was $49.87M, a decrease of -11.59% from the same quarter last year. In Q4, Maravai Lifesciences Holdings's net income was $-35.68M. See Maravai Lifesciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 185.74M$ 259.19M$ 288.94M$ 883.00M$ 799.24M
Gross Profit
$ 33.39M$ 108.31M$ 140.20M$ 714.04M$ 658.68M
Operating Expenses
$ 40.13M$ 343.93M$ 171.85M$ 139.83M$ 104.03M
Depreciation and Amortization
$ 60.87M$ 56.87M$ 48.78M$ 38.10M$ 24.75M
EBITDA
$ -147.11M$ -156.92M$ 712.41M$ 609.99M$ 585.78M
Operating Income
$ -6.74M$ -235.62M$ -31.65M$ 574.22M$ 554.64M
Other Income/Expenses
$ -228.24M$ -25.86M$ 649.38M$ -22.74M$ -23.88M
Pretax Income
$ -234.97M$ -261.48M$ 617.74M$ 551.47M$ 530.76M
Net Income
$ -130.77M$ -144.85M$ -119.03M$ 220.21M$ 182.04M
Per Share Metrics
Basic EPS
$ -0.91$ -1.05$ -0.90$ 1.67$ 1.59
Diluted EPS
$ -0.91$ -1.05$ -0.90$ 1.67$ 1.56
Weighted Average Shares Outstanding
 145.07M 137.91M 131.92M 131.54M 114.79M
Weighted Average Shares Outstanding (Diluted)
 145.07M 137.91M 131.92M 131.69M 121.97M
Currency in USD

Maravai Lifesciences Holdings Earnings and Revenue History